| A Study of How Insulin Peglispro (LY2605541) and Insulin Glargine Affect the Breakdown of Fat and Sugar in Type 1 Diabetics (NCT01925989) | Eli Lilly and Company | 2013-11-01 |
| Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults (NCT01994746) | Eli Lilly and Company | 2013-11-01 |
| A Study of LY2801653 in Healthy Participants (NCT01981408) | Eli Lilly and Company | 2013-11-01 |
| A Study of Baricitinib and Ciclosporin in Healthy Participants (NCT01968057) | Eli Lilly and Company | 2013-10-01 |
| A Study of [14C]-LY3023703 in Healthy Participants (NCT01965782) | Eli Lilly and Company | 2013-10-01 |
| A Study of LY3127760 in Healthy Participants (NCT01968070) | Eli Lilly and Company | 2013-10-01 |
| A Study of Baricitinib and Simvastatin in Healthy Participants (NCT01960140) | Eli Lilly and Company | 2013-10-01 |
| A Study of LY2157299 in Healthy Participants (NCT01965808) | Eli Lilly and Company | 2013-10-01 |
| A Safety Study of Mirikizumab (LY3074828) (NCT01947933) | Eli Lilly and Company | 2013-10-01 |
| A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 Diabetes (NCT01771250) | Eli Lilly and Company | 2013-10-01 |
| A Study of Baricitinib and Omeprazole in Healthy Participants (NCT01925144) | Eli Lilly and Company | 2013-10-01 |
| A Study of Evacetrapib in Japanese and Non-Japanese Participants (NCT01958489) | Eli Lilly and Company | 2013-10-01 |
| Evaluate the Immunogenicity of a Novel Glucagon Formulation (NCT01959334) | Eli Lilly and Company | 2013-09-01 |
| A Study of Baricitinib and Probenecid in Healthy Participants (NCT01937026) | Eli Lilly and Company | 2013-09-01 |
| An Open Label Extension Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain (NCT01914666) | Eli Lilly and Company | 2013-09-01 |
| A Study of Tadalafil for Duchenne Muscular Dystrophy (NCT01865084) | Eli Lilly and Company | 2013-09-01 |
| A Study of Duloxetine in Participants With Chronic Pain Due to Osteoarthritis in China (NCT01931475) | Eli Lilly and Company | 2013-09-01 |
| A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED) (NCT01937871) | Eli Lilly and Company | 2013-09-01 |
| A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations (NCT01897480) | Eli Lilly and Company | 2013-08-28 |
| A Study of LY2409021 in Participants With Different Levels of Kidney Function (NCT01929109) | Eli Lilly and Company | 2013-08-01 |
| A Study of LY3050258 in Healthy Participants (NCT01929707) | Eli Lilly and Company | 2013-08-01 |
| A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants (NCT01900652) | Eli Lilly and Company | 2013-08-01 |
| A Study of Baricitinib When Administered With Ketoconazole or Fluconazole in Healthy Participants (NCT01924299) | Eli Lilly and Company | 2013-08-01 |
| A Study of Baricitinib and Rifampicin in Healthy Participants (NCT01910311) | Eli Lilly and Company | 2013-08-01 |
| A Study of LY2940680 in Japanese Participants With Advanced Cancers (NCT01919398) | Eli Lilly and Company | 2013-08-01 |
| A Study of Carbon-14-Labeled LY2835219 ([^14C]-LY2835219) in Healthy Participants (NCT01913314) | Eli Lilly and Company | 2013-08-01 |
| A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer (NCT01874938) | Eli Lilly and Company | 2013-08-01 |
| A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA) (NCT01925157) | Eli Lilly and Company | 2013-08-01 |
| A Study of Baricitinib and Birth Control Pills in Healthy Females (NCT01896726) | Eli Lilly and Company | 2013-07-01 |
| Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo (NCT01900665) | Eli Lilly and Company | 2013-07-01 |
| A Study of Evacetrapib (LY2484595) in Healthy Participants (NCT01903434) | Eli Lilly and Company | 2013-07-01 |
| A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma (NCT01697514) | Eli Lilly and Company | 2013-07-01 |
| The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel (NCT01893281) | Eli Lilly and Company | 2013-07-01 |
| A Study of Evacetrapib and Rifampin in Healthy Participants (NCT01908582) | Eli Lilly and Company | 2013-07-01 |
| A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment (NCT01894568) | Eli Lilly and Company | 2013-07-01 |
| A Study of Evacetrapib and Digoxin in Healthy Participants (NCT01897493) | Eli Lilly and Company | 2013-07-01 |
| An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis (NCT01885078) | Eli Lilly and Company | 2013-06-27 |
| A Study of LY2605541 in Healthy Participants (NCT01877265) | Eli Lilly and Company | 2013-06-01 |
| A Study of LY3023703 Testing Pain Relief After Wisdom Teeth Removal (NCT01872910) | Eli Lilly and Company | 2013-06-01 |
| A Study of LY3025876 in Participants With Diabetes (NCT01870297) | Eli Lilly and Company | 2013-06-01 |
| A Pharmacokinetic Study of Baricitinib in Participants With Liver Disease (NCT01870388) | Eli Lilly and Company | 2013-06-01 |
| A Study of LY2605541 and Insulin Lispro Mixture in Healthy Participants (NCT01871493) | Eli Lilly and Company | 2013-06-01 |
| A Study of LY3015014 in Participants With High Cholesterol (NCT01890967) | Eli Lilly and Company | 2013-06-01 |
| A Study of Multiple Doses of LY2922470 in Participants With Diabetes (NCT01867216) | Eli Lilly and Company | 2013-06-01 |
| A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (NCT01763788) | Eli Lilly and Company | 2013-05-07 |
| A Study of LY3002813 in Participants With Alzheimer's Disease (NCT01837641) | Eli Lilly and Company | 2013-05-03 |
| A Study of LY3045697 After Multiple Oral Dosing in Healthy Participants (NCT01821703) | Eli Lilly and Company | 2013-05-01 |
| A Drug Drug Interaction (DDI) Study of Baricitinib (LY3009104) and Digoxin in Healthy Participants (NCT01859078) | Eli Lilly and Company | 2013-05-01 |
| A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing (NCT01808651) | Eli Lilly and Company | 2013-05-01 |
| A Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain (NCT01855919) | Eli Lilly and Company | 2013-05-01 |
| A Study of LY3084077 in Healthy Participants (NCT01846702) | Eli Lilly and Company | 2013-05-01 |
| A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy (NCT01816295) | Eli Lilly and Company | 2013-05-01 |
| The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the Bloodstream (NCT01836198) | Eli Lilly and Company | 2013-05-01 |
| A Multiple Dose Study of LY3023703 in Healthy Participants (NCT01849055) | Eli Lilly and Company | 2013-05-01 |
| A Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants (NCT01825876) | Eli Lilly and Company | 2013-04-01 |
| A Study of Evacetrapib (LY2484595) in Participants With Severe Renal Impairment and in Healthy Participants (NCT01825889) | Eli Lilly and Company | 2013-04-01 |
| A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD) (NCT01794000) | Eli Lilly and Company | 2013-04-01 |
| A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairment (NCT01836185) | Eli Lilly and Company | 2013-04-01 |
| Study of LY2835219 for Mantle Cell Lymphoma (NCT01739309) | Eli Lilly and Company | 2013-03-20 |
| A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer (NCT01788566) | Eli Lilly and Company | 2013-03-01 |
| A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes (NCT01790438) | Eli Lilly and Company | 2013-03-01 |
| A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease (NCT01807026) | Eli Lilly and Company | 2013-03-01 |
| A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing (NCT01808612) | Eli Lilly and Company | 2013-03-01 |
| Study of Food on Evacetrapib (LY2484595) in Healthy Participants (NCT01810432) | Eli Lilly and Company | 2013-03-01 |
| A Study of LY2605541 in Healthy Participants and in the Elderly (NCT01818245) | Eli Lilly and Company | 2013-03-01 |
| Study of LY3016859 in Participants With Diabetic Nephropathy (NCT01774981) | Eli Lilly and Company | 2013-03-01 |
| Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis (NCT01777191) | Eli Lilly and Company | 2013-03-01 |
| A Study of Nasal Glucagon in Participants With a Common Cold (NCT02778100) | Eli Lilly and Company | 2013-03-01 |
| A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer (NCT01632306) | Eli Lilly and Company | 2013-03-01 |
| A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes (NCT01784211) | Eli Lilly and Company | 2013-02-01 |
| Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes (NCT01774968) | Eli Lilly and Company | 2013-02-01 |
| A Study of Two Dosage Forms of LY2886721 in Healthy Participants (NCT01775904) | Eli Lilly and Company | 2013-02-01 |
| A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes (NCT01769404) | Eli Lilly and Company | 2013-02-01 |
| A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus (NCT01792284) | Eli Lilly and Company | 2013-02-01 |
| A Study of LY3045697 in Healthy Participants (NCT01750853) | Eli Lilly and Company | 2013-01-01 |
| A Study of LY2157299 Monohydrate in Healthy Volunteers (NCT01746004) | Eli Lilly and Company | 2013-01-01 |
| A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NCT01769391) | Eli Lilly and Company | 2013-01-01 |
| A Study of LY2940680 in Healthy Participants (NCT01746745) | Eli Lilly and Company | 2013-01-01 |
| Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8) (NCT01769378) | Eli Lilly and Company | 2013-01-01 |
| Comparison of Insulin Mix25 Versus Mix50 (NCT01773473) | Eli Lilly and Company | 2013-01-01 |
| A Study of LY2940680 in Small Cell Lung Cancer (NCT01722292) | Eli Lilly and Company | 2013-01-01 |
| Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis (NCT01753856) | Eli Lilly and Company | 2013-01-01 |
| A Moderate to Severe Rheumatoid Arthritis Study (NCT01721044) | Eli Lilly and Company | 2013-01-01 |
| A Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer (NCT01703091) | Eli Lilly and Company | 2012-12-01 |
| A Study in Moderate to Severe Rheumatoid Arthritis Participants (NCT01721057) | Eli Lilly and Company | 2012-12-01 |
| A Study of LY3053102 in Healthy Participants (NCT01736241) | Eli Lilly and Company | 2012-12-01 |
| A Study of LY2922470 in Healthy Participants and Participants With Diabetes (NCT01746017) | Eli Lilly and Company | 2012-12-01 |
| A Study of LY2922083 in Healthy Participants and Participants With Diabetes (NCT01748552) | Eli Lilly and Company | 2012-12-01 |
| A Study of Evacetrapib in Healthy Participants (NCT01736254) | Eli Lilly and Company | 2012-12-01 |
| A Single Dose Study of LY2605541 in Participants With Liver Impairment (NCT01751399) | Eli Lilly and Company | 2012-12-01 |
| A Study of Evacetrapib in Healthy Female Participants (NCT01746732) | Eli Lilly and Company | 2012-12-01 |
| A Study of Ixekizumab in Participants With Active Psoriatic Arthritis (NCT01695239) | Eli Lilly and Company | 2012-12-01 |
| Study of LY2157299 in Japanese Participants With Cancer (NCT01722825) | Eli Lilly and Company | 2012-11-01 |
| A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy Participants (NCT01725451) | Eli Lilly and Company | 2012-11-01 |
| A Study in Participants With Moderate to Severe Rheumatoid Arthritis (NCT01711359) | Eli Lilly and Company | 2012-11-01 |
| A Study in Participants With Advanced Solid Tumors (NCT01682135) | Eli Lilly and Company | 2012-11-01 |
| A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI (NCT01634555) | Eli Lilly and Company | 2012-10-01 |
| A Study of LY3039478 in Participants With Advanced Cancer (NCT01695005) | Eli Lilly and Company | 2012-10-01 |
| A Study of Evacetrapib in High-Risk Vascular Disease (NCT01687998) | Eli Lilly and Company | 2012-10-01 |
| A Study in Moderate to Severe Rheumatoid Arthritis (NCT01710358) | Eli Lilly and Company | 2012-10-01 |